Functional studies in murine models of LCMV infection and melanoma demonstrated that deletion of Runx3 results in a dramatic reduction, ranging from 50- to 150-fold in CD8+ T cells expressing CD69 and CD103 across various tissues, including salivary glands, kidneys, skin, and lungs (138). Here, CD69 is linked to melanoma.